BI Weekend: Warner Discovery Splits, Walmart Credit Cards
Bloomberg Intelligence
00:00
Biotech Trends and Nuclear Energy Insights
This chapter examines the trend of biotech firms returning cash to shareholders amidst investor dissatisfaction, and discusses Moderna's updated COVID vaccine and its trials. It also explores the United States' goals for increasing nuclear energy generation by 2050, highlighting both the potential benefits for tech companies and the challenges posed by historical safety concerns and high costs. Additionally, it addresses the complexities of government subsidies for energy projects and the importance of immediate solutions to meet rising energy demands.
Transcript
Play full episode
